| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,658 |
16,757 |
$1.46M |
| 76830 |
Ultrasound, transvaginal |
12,049 |
11,859 |
$1.22M |
| 81514 |
|
2,636 |
2,631 |
$576K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
11,255 |
10,372 |
$523K |
| 93976 |
|
3,994 |
3,982 |
$512K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
4,970 |
4,934 |
$433K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
9,303 |
9,229 |
$249K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
9,302 |
9,228 |
$249K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,415 |
2,414 |
$205K |
| 59840 |
|
910 |
910 |
$172K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,291 |
1,924 |
$167K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,662 |
1,658 |
$161K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
5,180 |
5,140 |
$139K |
| 84410 |
|
3,466 |
3,447 |
$138K |
| 81025 |
|
16,335 |
15,733 |
$90K |
| 58558 |
|
74 |
74 |
$88K |
| 99385 |
|
879 |
878 |
$76K |
| 82157 |
|
3,352 |
3,333 |
$76K |
| 82670 |
|
3,399 |
3,379 |
$74K |
| 84403 |
|
3,464 |
3,445 |
$69K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
693 |
692 |
$68K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
3,264 |
3,260 |
$61K |
| 82627 |
|
3,466 |
3,447 |
$60K |
| 84144 |
|
3,558 |
3,534 |
$58K |
| 84146 |
|
3,474 |
3,453 |
$52K |
| 83001 |
|
3,484 |
3,462 |
$50K |
| 83002 |
|
3,482 |
3,461 |
$50K |
| 86696 |
|
3,333 |
3,330 |
$50K |
| 84270 |
|
3,470 |
3,445 |
$49K |
| 57454 |
|
298 |
297 |
$43K |
| 84481 |
|
3,446 |
3,428 |
$42K |
| 86800 |
|
3,452 |
3,433 |
$42K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,443 |
3,424 |
$41K |
| 99442 |
|
593 |
567 |
$40K |
| 82785 |
|
3,162 |
3,144 |
$40K |
| 86376 |
|
3,450 |
3,431 |
$39K |
| 86780 |
|
3,602 |
3,585 |
$37K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
542 |
542 |
$37K |
| 84702 |
|
3,195 |
3,101 |
$37K |
| 86769 |
|
787 |
787 |
$33K |
| 86695 |
|
3,346 |
3,336 |
$32K |
| 86803 |
|
3,130 |
3,125 |
$31K |
| 86704 |
|
3,551 |
3,535 |
$30K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
209 |
191 |
$29K |
| 86705 |
|
3,379 |
3,364 |
$28K |
| 86706 |
|
3,544 |
3,528 |
$27K |
| 99441 |
|
679 |
649 |
$26K |
| 87340 |
|
3,318 |
3,313 |
$24K |
| 84439 |
|
3,436 |
3,417 |
$24K |
| 81002 |
|
13,735 |
13,172 |
$21K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
929 |
929 |
$14K |
| 82607 |
|
1,181 |
1,178 |
$14K |
| 82668 |
|
942 |
942 |
$14K |
| 82728 |
|
1,184 |
1,181 |
$13K |
| 82746 |
|
1,184 |
1,181 |
$12K |
| 80074 |
|
250 |
250 |
$9K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
68 |
68 |
$6K |
| 84432 |
|
481 |
472 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
426 |
419 |
$5K |
| 86708 |
|
439 |
438 |
$4K |
| 99386 |
|
43 |
43 |
$4K |
| 84703 |
|
631 |
612 |
$3K |
| S0190 |
Mifepristone, oral, 200 mg |
12 |
12 |
$3K |
| 58120 |
|
12 |
12 |
$3K |
| 99401 |
|
85 |
85 |
$3K |
| 86304 |
|
160 |
159 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
16 |
16 |
$2K |
| 82166 |
|
67 |
66 |
$2K |
| 58300 |
|
13 |
12 |
$1K |
| 82378 |
|
96 |
95 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
1,592 |
1,569 |
$1K |
| 82105 |
|
113 |
112 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
68 |
66 |
$772.67 |
| 83520 |
|
40 |
40 |
$495.69 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
21 |
21 |
$477.98 |
| 86777 |
|
29 |
29 |
$340.92 |
| 86765 |
|
26 |
26 |
$283.69 |
| 86778 |
|
17 |
17 |
$217.77 |
| 86709 |
|
286 |
283 |
$200.20 |
| 86762 |
|
14 |
14 |
$179.06 |
| 86644 |
|
14 |
14 |
$179.06 |
| 84402 |
|
1,921 |
1,910 |
$88.30 |
| S0191 |
Misoprostol, oral, 200 mcg |
12 |
12 |
$57.60 |
| 87481 |
|
20 |
18 |
$31.19 |
| 99072 |
|
434 |
380 |
$0.01 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
108 |
96 |
$0.00 |
| 99000 |
|
27 |
25 |
$0.00 |